Equities

Japan Lifeline Co Ltd

Japan Lifeline Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,153.00
  • Today's Change11.00 / 0.96%
  • Shares traded94.70k
  • 1 Year change+11.94%
  • Beta0.5923
Data delayed at least 20 minutes, as of Jul 04 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.

  • Revenue in JPY (TTM)51.38bn
  • Net income in JPY7.52bn
  • Incorporated1981
  • Employees1.22k
  • Location
    Japan Lifeline Co Ltd25F, NYK Tennoz Bldg.,2-2-20, Higashi-ShinagawaSHINAGAWA-KU 140-0002JapanJPN
  • Phone+81 367115200
  • Websitehttps://www.jll.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CI Medical Co Ltd46.58bn1.81bn45.90bn473.0025.382.2913.920.985536.1636.16931.59401.251.284.1413.8098,467,230.005.0510.839.2715.6526.1427.733.946.060.4352--0.460412.836.3812.07-17.419.3877.2413.65
France Bed Holdings Co Ltd59.15bn3.13bn47.65bn1.78k14.301.125.460.805686.7886.781,639.201,106.360.88783.245.8033,174,990.004.703.856.185.2453.9152.365.304.411.90--0.324144.960.97822.7015.993.81-1.019.30
Medikit Co Ltd21.85bn3.07bn52.69bn966.0015.540.988111.872.41189.68189.681,337.982,982.560.41953.664.0322,619,610.005.895.756.556.3140.0640.0514.0514.085.3512,203.360.017238.881.133.387.153.56-0.600512.20
Japan Eyewear Holdings Co Ltd14.47bn2.80bn74.35bn542.0026.655.4717.175.14116.51116.51601.39567.190.43712.2114.5026,699,260.008.47--10.42--77.60--19.38--1.3010.550.5555--26.17--659.25------
Tokai Corp (Gifu)138.22bn5.81bn80.62bn4.25k13.550.91397.650.5833165.03165.033,926.202,447.901.2219.076.9232,492,240.005.195.506.587.1124.3424.764.244.542.37--0.026427.316.173.51-4.852.9432.2914.09
Eiken Chemical Co Ltd40.05bn2.63bn84.64bn757.0031.141.6517.062.1170.5270.521,081.031,328.720.62622.833.4052,908,850.004.128.015.0610.1441.7645.926.5811.502.62--0.086235.45-7.442.29-54.08-5.2411.6611.20
Shofu Inc35.08bn3.66bn84.91bn1.37k23.132.0317.522.42205.19205.191,969.572,340.480.74781.519.2925,624,540.007.846.158.967.0059.8557.7610.488.122.66--0.010931.8410.747.0816.5924.935.0321.94
Japan Lifeline Co., Ltd.51.38bn7.52bn86.52bn1.22k11.591.479.631.6898.5598.55675.02775.420.69371.443.8842,256,580.0010.158.6312.5710.8860.3057.2814.6312.281.96--0.073948.80-0.70732.459.06-0.54465.407.69
Nagaileben Co., Ltd.16.64bn2.94bn90.70bn511.0027.551.8943.685.4592.1292.12520.881,344.120.3561.562.7032,564,670.006.297.716.748.3643.4745.3317.6720.3510.85----55.77-3.180.0433-14.61-2.58-20.390.00
HOGY MEDICAL CO., LTD.39.10bn2.80bn101.41bn1.41k34.751.1310.792.59115.55115.551,611.173,547.480.38672.844.9927,769,890.002.764.243.064.6733.4139.767.1411.584.07--0.061845.680.30531.30-35.03-14.247.944.56
Menicon Co Ltd116.19bn4.54bn101.56bn4.22k24.071.248.130.87455.0655.061,433.511,072.690.69933.059.1327,527,130.002.734.533.525.6752.5152.973.915.721.3420.670.463927.125.447.51-38.484.8832.6112.30
Data as of Jul 04 2024. Currency figures normalised to Japan Lifeline Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

17.92%Per cent of shares held by top holders
HolderShares% Held
Sompo Asset Management Co. Ltd.as of 15 Mar 20244.11m5.42%
The Vanguard Group, Inc.as of 06 Jun 20242.48m3.27%
Nomura Asset Management Co., Ltd.as of 31 May 20241.74m2.30%
Dimensional Fund Advisors LPas of 06 Jun 2024939.10k1.24%
Nikko Asset Management Co., Ltd.as of 07 Jun 2024918.70k1.21%
BlackRock Fund Advisorsas of 06 Jun 2024882.20k1.16%
Daiwa Asset Management Co. Ltd.as of 31 May 2024785.00k1.04%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 06 Jun 2024727.90k0.96%
Norges Bank Investment Managementas of 31 Dec 2023640.79k0.85%
State Board of Administration of Florida Retirement Systemas of 30 Jun 2023359.40k0.47%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.